News Release
A summary of results for continuing operations for the three months and years ended December 31, 2007 and 2006 is shown below:
(In Millions, Except Per-Share Data) Three Months Ended Years Ended
December 31 December 31
2007 2006 2007 2006
Sales $208.5 $227.0 $922.6 $937.6
Income from continuing operations
as reported under generally accepted
accounting principles (GAAP) $7.0 $9.8 $34.9 $35.3
After-tax effects of:
Loss associated with plant shutdowns,
asset impairments and restructurings 1.0 .4 5.2 3.3
(Gains) losses from sale of assets
and other items (1.7) (.9) (1.7) (2.5)
Income from continuing manufacturing
operations* $6.3 $9.3 $38.4 $36.1
Diluted earnings per share from
continuing operations as reported
under GAAP $.19 $.25 $.90 $.91
After-tax effects per diluted share of:
Loss associated with plant shutdowns,
asset impairments and restructurings .03 .01 .13 .08
(Gains) losses from sale of assets
and other items (.05) (.02) (.04) (.06)
Diluted earnings per share from
continuing manufacturing operations* $.17 $.24 $.99 $.93
*The after-tax effects of unusual items, plant shutdowns, asset
impairments and restructurings, and gains or losses from sale of assets
and other items have been presented separately and removed from net
income and earnings per share from continuing operations as reported
under GAAP to determine Tredegar's presentation of income and earnings
per share from continuing manufacturing operations. Income and earnings
per share from continuing manufacturing operations are key financial and
analytical measures used by Tredegar to gauge the operating performance
of its continuing manufacturing businesses. They are not intended to
represent the stand-alone results for Tredegar's continuing manufacturing
businesses under GAAP and should not be considered as an alternative to
net income or earnings per share as defined by GAAP. They exclude items
that we believe do not relate to Tredegar's ongoing manufacturing
operations.
John D. Gottwald, Tredegar's president and chief executive officer, said: "Earnings from continuing manufacturing operations declined by 7 cents per share or 29% in the fourth quarter of 2007 compared with the fourth quarter of 2006 due to lower operating profits in both films and our remaining aluminum extrusions business in the U.S. Operating profits in films declined in the fourth quarter of 2007 compared with the fourth quarter of 2006 due primarily to the lag in the pass-through of changes in resin costs and adjustments for inventories accounted for under the last-in first-out method. Excluding the impact of these items, operating profits in films were up in the fourth quarter of 2007 as a result of higher sales of apertured materials, improved product mix of surface protection films and appreciation of the U.S. dollar value of currencies for operations outside of the U.S. Future operating profit levels in films will depend on our ability to deliver product innovations and cost reductions to support growth in the sales of higher value surface protection films and to address competitive pressures facing our personal care and packaging materials businesses."
Mr. Gottwald continued: "The sale of our aluminum extrusions business in Canada, which was suffering from operating losses driven by lower volume and higher conversion costs from appreciation of the Canadian dollar, allows us to focus on our U.S. aluminum extrusions operations where we have more control over costs and profitability. However, business conditions in the U.S. continue to be challenging. Demand for extruded aluminum shapes is down significantly in most market segments. While we are very focused on controlling costs during this downturn, we are also investing for a future rebound. In January, we announced plans to spend approximately $24 million over the next 18 months to expand our capacity at our plant in Carthage, Tennessee. Approximately 65% of our sales of aluminum extrusions from our U.S. operations are related to non-residential construction, and this additional capacity will increase our capabilities in this sector."
Mr. Gottwald further stated: "During 2007 we used a portion of a standing authorization from our board of directors to repurchase approximately 4.8 million shares of our stock at an average price of $16.00 per share. Despite the significant funds used for this program, our net debt at December 31, 2007 increased by only $12.2 million to $33.8 million due to strong cash flow from operations and lower capital expenditures."
MANUFACTURING OPERATIONS
Film Products
Fourth-quarter net sales in Film Products were $130.6 million, up 1.6% from $128.5 million in the fourth quarter of 2006, while operating profit from ongoing operations decreased to $12.9 million in the fourth quarter of 2007 from $15.0 million in 2006. Volume was 58.6 million pounds in the fourth quarter of 2007 compared with 62.7 million pounds in the fourth quarter of 2006.
Volume was down in the fourth quarter of 2007 compared with the fourth quarter of 2006 primarily due to a decrease in sales of certain barrier films and certain surface protection films, partially offset by an increase in sales of apertured materials used as topsheet in feminine hygiene products. Net sales increased primarily due to appreciation of the U.S. dollar value of currencies for operations outside of the U.S. and higher sales of apertured materials and higher value surface protection films, partially offset by the decline in volume.
Operating profit from ongoing operations decreased in the fourth quarter of 2007 compared with the fourth quarter of 2006 due primarily to the lag in the pass-through of changes in resin costs and adjustments for inventories accounted for under the last-in first-out method ("LIFO"). Excluding the impact of these items, operating profits in Film Products were up in the fourth quarter of 2007 as a result of higher sales of apertured materials, improved product mix of surface protection films and appreciation of the U.S. dollar value of currencies for operations outside of the U.S. (the benefit from currency rate changes was approximately $1.0 million). The company estimates that the impact of the lag in the pass-through of changes in average resin costs and adjustments for LIFO had a negative impact on operating profit of approximately $2.0 million in the fourth quarter of 2007 compared with an estimated positive impact on operating profit of $3.5 million in the fourth quarter of 2006. Film Products has index-based pass-through raw material cost agreements for the majority of its business. However, under certain agreements, changes in resin prices are not passed through for an average period of 90 days. In addition, operating profit in the fourth quarter of 2006 benefited from a customer reimbursement of $1 million for certain new product start-up costs that were incurred during the first half of 2006.
Net sales in Film Products were $531.0 million in 2007, up 3.9% versus $511.2 million in 2006. Operating profit from ongoing operations was $59.4 million in 2007, up 3.1% compared with $57.6 million in 2006. Volume decreased to 244.3 million pounds in 2007 from 253.5 million pounds in 2006.
Volume was down in 2007 compared with 2006 primarily due to a decrease in sales of commodity barrier films and packaging films, partially offset by an increase in sales of elastic materials used in baby diapers and adult incontinence products and apertured materials used as topsheet in feminine hygiene products. Certain commodity barrier films were discontinued in conjunction with the shutdown in the second quarter of 2006 of the plant in LaGrange, Georgia. Net sales increased primarily due to appreciation of the U.S. dollar value of currencies for operations outside of the U.S., higher volume of elastic and apertured materials and improved product mix of surface protection films, partially offset by a decline in volume of commodity barrier films and a decline in volume and prices of certain packaging films.
Operating profit from ongoing operations in Film Products increased in 2007 versus 2006 primarily due to the net changes in sales noted above and appreciation of the U.S. dollar value of currencies for operations outside of the U.S. (the benefit from currency rate changes was approximately $3.0 million), partially offset by an estimated negative impact in 2007 of $2.5 million from the lag in the pass-through of changes in average resin costs and year-end adjustments for LIFO. In 2006, the company estimated a favorable impact of $4.5 million from the lag in the pass-through of changes in average resin costs and year-end adjustments for LIFO.
Capital expenditures in Film Products were $15.3 million in 2007, down from $33.2 million in 2006, and are projected to be approximately $33 million in 2008. Depreciation expense was $33.9 million in 2007, up from $31.7 million in 2006, and is projected to be $33 million in 2008.
Aluminum Extrusions
Fourth-quarter net sales from continuing operations in Aluminum Extrusions were $73.5 million, down 21% from $93.0 million in the fourth quarter of 2006. Operating profit from ongoing U.S. operations decreased to $2.6 million in the fourth quarter of 2007, down 40% from $4.3 million in the fourth quarter of 2006. Volume from continuing operations decreased to 32.2 million pounds in the fourth quarter of 2007, down 21% from 40.7 million pounds in the fourth quarter of 2006.
Net sales from continuing operations in Aluminum Extrusions were $371.8 million in 2007, down 7.9% from $403.8 million in 2006. Operating profit from ongoing U.S. operations decreased to $16.5 million in 2007, down 9.8% from $18.3 million in 2006. Volume from continuing operations decreased to 155.8 million pounds in 2007, down 15.9% from 185.2 million pounds in 2006.
The decreases in net sales and ongoing operating profit from continuing operations in the fourth quarter and full year were mainly due to lower volume, partially offset by higher selling prices. Shipments declined in most markets, especially extrusions used in hurricane protection products and residential construction. In addition, the company began experiencing a softening of markets for extrusions used in non-residential construction in the fourth quarter of 2007. Overall backlog for continuing operations in Aluminum Extrusions at December 31, 2007 was down by approximately 7% compared with December 31, 2006.
Capital expenditures for continuing operations in Aluminum Extrusions were $4.4 million in 2007, down from $6.6 million in 2006, and are projected to be approximately $21 million in 2008. In January, Tredegar announced plans to spend approximately $24 million over the next 18 months to expand the capacity at its plant in Carthage, Tennessee. Depreciation expense was $8.5 million in 2007, up slightly from $8.4 million in 2006, and is projected to be $8.5 million in 2008.
On February 12, 2008, Tredegar sold its aluminum extrusions business in Canada for an estimated purchase price of $25.5 million to WXP Holdings, Inc., an affiliate of H.I.G. Capital. The final purchase price is subject to increase or decrease to the extent that actual working capital as of February 12, 2008 is above or below the estimated working capital used to determine the estimated purchase price. Tredegar expects to realize cash income tax benefits in 2008 from the sale of approximately $11.4 million, which the company recognized as a deferred income tax asset in its consolidated balance sheet at December 31, 2007. All historical results for this business have been reflected as discontinued operations in the accompanying financial tables.
OTHER ITEMS
Net pension income from continuing operations was $718,000 in the fourth quarter of 2007 and $2.8 million in 2007, a favorable change of $1.2 million (2 cents per share after taxes) and $4.5 million (8 cents per share after taxes) from amounts recognized in the fourth quarter and all of 2006, respectively. Most of the favorable changes relate to a pension plan that is reflected in "Corporate expenses, net" in the operating profit by segment table. Net pension income from continuing operations is expected to be $5.5 million in 2008. The company contributed approximately $167,000 to its pension plans for continuing operations in 2007 and expects to contribute a similar amount in 2008.
Interest expense was $712,000 in the fourth quarter of 2007 and $2.7 million in 2007, a decline of $577,000 (1 cent per share after taxes) and $2.8 million (5 cents per share after taxes) versus the fourth quarter and all of 2006, respectively, due to lower average debt outstanding.
The effective tax rate used to compute income taxes from continuing manufacturing operations was 44.7% in the fourth quarter of 2007 and 38.8% in 2007, compared with 34.7% in the fourth quarter of 2006 and 36.5% in 2006. The increase in the effective tax rate for continuing manufacturing operations for 2007 versus 2006, which had an unfavorable impact of approximately 4 cents per share, was mainly due to lower income tax benefits expected for the Domestic Production Activities Deduction and the research & development tax credit. The increase in the effective tax rate for continuing manufacturing operations during the fourth quarter of 2007 versus 2006, which had an unfavorable impact of approximately 3 cents per share, was mainly due to the adjustment of income taxes during the fourth quarter to the rate for the entire year.
During the first quarter of 2007, the company adopted new accounting standards for maintenance costs and uncertain income tax positions, neither of which had a material impact on Tredegar's results of operations or financial condition. In addition, Tredegar adopted new accounting standards on fair value measurements and the fair value option for financial assets and liabilities, neither of which had an impact on historical results at the date of adoption.
Overall results for continuing operations for the year include special items. After-tax charges for continuing operations for plant shutdowns, asset impairments and restructurings were 3 cents and 1 cent per share in the fourth quarters of 2007 and 2006, respectively. After-tax charges for continuing operations for plant shutdowns, asset impairments and restructurings were 13 cents and 8 cents per share in all of 2007 and 2006, respectively. In addition, the results for the fourth quarter and all of 2007 include an after-tax gain of $1.7 million (5 cents and 4 cents per share, respectively) from the sale of real estate. Results for the fourth quarter and all of 2006 include after-tax income of $902,000 (2 cents per share) and $2.5 million (6 cents per share) for the reversal of certain valuation allowances relating to deferred tax assets and gains from the sale of equipment and liquidation of inventories accounted for under LIFO at the films plant shut down in LaGrange, Georgia. Further details regarding these items are provided in the financial tables included with this press release.
As discussed in the company's second quarter earnings press release, on April 2, 2007 Tredegar invested $10 million in Harbinger Capital Partners Special Situations Fund, L.P. ("Harbinger"). At December 31, 2007, Harbinger reported Tredegar's capital account value at $23.0 million reflecting $13.0 million of unrealized appreciation ($8.3 million or 22 cents per share after taxes) versus the carrying value in Tredegar's balance sheet of $10 million.
On August 31, 2007, Tredegar invested $6.5 million in a privately held drug delivery company representing ownership on a fully diluted basis of approximately 23%. This company is developing and commercializing state of the art drug delivery systems designed to improve patient compliance and outcomes. During 2007, Tredegar invested $6.2 million in real estate. At December 31, 2007, the carrying value in Tredegar's balance sheet of its investments in this real estate and the drug delivery company equaled the respective amounts invested.
CAPITAL STRUCTURE AND ADJUSTED EBITDA
Net debt (debt in excess of cash) was $33.8 million at December 31, 2007, compared with net debt of $21.6 million at December 31, 2006. Adjusted EBITDA from continuing manufacturing operations, a key valuation and borrowing capacity measure, was $107.9 million in 2007 compared with $102.5 million in 2006. See notes to financial statements and tables for reconciliations to comparable GAAP measures.
On January 7, 2008, Tredegar announced that its board of directors approved a share repurchase program whereby management is authorized at its discretion to purchase, in the open market or in privately negotiated transactions, up to 5 million shares of Tredegar's outstanding common stock. This share repurchase program replaces Tredegar's previous share repurchase authorization. The authorization has no time limit. During the fourth quarter of 2007, Tredegar repurchased 3.1 million shares for $48.3 million under its previous authorization. As of January 4, 2008, Tredegar had approximately 34.7 million common shares outstanding.
FORWARD-LOOKING AND CAUTIONARY STATEMENTS
Some of the information contained in this press release may constitute "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. When we use the words "believe," "estimate," "anticipate," "expect," "project," "likely," "may" and similar expressions, we do so to identify forward-looking statements. Such statements are based on our then current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those addressed in the forward-looking statements. It is possible that our actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in these forward-looking statements. Factors that could cause actual results to differ from expectations include, without limitation: Film Products is highly dependent on sales to one customer -- The Procter & Gamble Company; growth of Film Products depends on its ability to develop and deliver new products at competitive prices; sales volume and profitability of continuing operations in Aluminum Extrusions is cyclical and highly dependent on economic conditions of end-use markets in the U.S., particularly in the construction, distribution and transportation industries and are also subject to seasonal slowdowns; our substantial international operations subject us to risks of doing business in foreign countries, which could adversely affect our business, financial condition and results of operations; our future performance is influenced by costs incurred by our operating companies including, for example, the cost of energy and raw materials; and the factors discussed in the reports Tredegar files with or furnishes to the Securities and Exchange Commission (the "SEC") from time-to-time, including the risks and important factors set forth in "Risk Factors" in Part I, Item 1A of our 2007 Annual Report on Form 10-K that will be filed with the SEC.
Tredegar does not undertake to update any forward-looking statement made in this press release to reflect any change in management's expectations or any change in conditions, assumptions or circumstances on which such statements are based.
To the extent that the financial information portion of this release contains non-GAAP financial measures, it also presents both the most directly comparable financial measures calculated and presented in accordance with GAAP and a quantitative reconciliation of the difference between any such non-GAAP measures and such comparable GAAP financial measures. Accompanying the reconciliation is management's statement concerning the reasons why management believes that presentation of non-GAAP measures provides useful information to investors concerning Tredegar's financial condition and results of operations.
Based in Richmond, Va., Tredegar Corporation is a global manufacturer of plastic films and aluminum extrusions.
Tredegar Corporation
Condensed Consolidated Statements of Income
(In Thousands, Except Per-Share Data)
(Unaudited)
Fourth Quarter Ended Year Ended
December 31 December 31
2007 2006 2007 2006
Sales $208,462 $226,995 $922,583 $937,561
Other income (expense), net
(a) (b) 3,315 710 1,782 1,444
211,777 227,705 924,365 939,005
Cost of goods sold (a) 171,396 187,355 761,509 779,376
Freight 4,352 5,564 19,808 22,602
Selling, R&D and general
expenses 21,135 18,620 76,855 72,170
Amortization of intangibles 37 37 149 149
Interest expense 712 1,289 2,721 5,520
Asset impairments and costs
associated with exit and
disposal activities (a) 1,456 670 4,027 4,080
199,088 213,535 865,069 883,897
Income from continuing
operations before income taxes 12,689 14,170 59,296 55,108
Income taxes (b) 5,653 4,334 24,366 19,791
Income from continuing
operations 7,036 9,836 34,930 35,317
Income (loss) from discontinued
operations (c) 6,321 1,210 (19,681) 2,884
Net income (a) (b) (d) $13,357 $11,046 $15,249 $38,201
Earnings (loss) per share:
Basic:
Continuing operations $.19 $.25 $.91 $.92
Discontinued operations .17 .03 (.51) .07
Net income $.36 $.28 $.40 $.99
Diluted:
Continuing operations $.19 $.25 $.90 $.91
Discontinued operations .17 .03 (.51) .07
Net income $.36 $.28 $.39 $.98
Shares used to compute earnings
(loss) per share:
Basic 36,494 38,793 38,532 38,671
Diluted 36,587 39,092 38,688 38,931
Tredegar Corporation
Net Sales and Operating Profit by Segment
(In Thousands)
(Unaudited)
Fourth Quarter Ended Year Ended
December 31 December 31
2007 2006 2007 2006
Net Sales
Film Products $130,587 $128,472 $530,972 $511,169
Aluminum Extrusions 73,523 92,959 371,803 403,790
Total net sales 204,110 221,431 902,775 914,959
Add back freight 4,352 5,564 19,808 22,602
Sales as shown in the
Consolidated Statements
of Income $208,462 $226,995 $922,583 $937,561
Operating Profit
Film Products:
Ongoing operations $12,915 $15,034 $59,423 $57,645
Plant shutdowns, asset
impairments and restructurings,
net of gains on sale of assets
and related income from LIFO
inventory liquidations (a) (256) 14 (649) 221
Aluminum Extrusions (c):
Ongoing operations 2,641 4,259 16,516 18,302
Plant shutdowns, asset
impairments and restructurings
(a) - - (634) (1,434)
AFBS (e):
Loss on investment in Therics, LLC - - - (25)
Plant shutdowns, asset
impairments and
restructurings (a) (1,200) (143) (2,786) (637)
Total 14,100 19,164 71,870 74,072
Interest income 252 418 1,212 1,240
Interest expense 712 1,289 2,721 5,520
Gain on the sale of corporate
assets (b) 2,699 - 2,699 56
Loss from write-down of an
investment (b) - - 2,095 -
Stock option-based compensation
costs (f) 277 262 978 970
Corporate expenses, net 3,373 3,861 10,691 13,770
Income from continuing operations
before income taxes 12,689 14,170 59,296 55,108
Income taxes (b) 5,653 4,334 24,366 19,791
Income from continuing operations 7,036 9,836 34,930 35,317
Income (loss) from discontinued
operations (c) 6,321 1,210 (19,681) 2,884
Net income (a) (b) (d) $13,357 $11,046 $15,249 $38,201
Tredegar Corporation
Condensed Consolidated Balance Sheets
(In Thousands)
(Unaudited)
As of December 31,
2007 2006
Assets
Cash & cash equivalents $48,217 $40,898
Accounts & notes receivable, net 97,064 106,955
Income taxes recoverable 323 10,975
Inventories 48,666 48,664
Deferred income taxes 9,172 6,055
Prepaid expenses & other 4,077 4,428
Current assets of discontinued
operation (c) 37,750 35,275
Total current assets 245,269 253,250
Property, plant & equipment, net 269,083 287,435
Other assets (g) 116,759 63,712
Goodwill & other intangibles 135,907 132,237
Noncurrent assets of discontinued
operation (c) 17,460 45,153
Total assets $784,478 $781,787
Liabilities and Shareholders' Equity
Accounts payable $67,161 $54,020
Accrued expenses 33,676 38,790
Current portion of long-term debt 540 678
Current liabilities of discontinued
operation (c) 17,152 18,522
Total current liabilities 118,529 112,010
Long-term debt 81,516 61,842
Deferred income taxes 68,625 65,732
Other noncurrent liabilities (g) 15,662 14,299
Noncurrent liabilities of discontinued
operation (c) 8,818 11,309
Shareholders' equity (c) (g) 491,328 516,595
Total liabilities and shareholders'
equity $784,478 $781,787
Tredegar Corporation
Condensed Consolidated Statement of Cash Flows
(In Thousands)
(Unaudited)
Year Ended
December 31
2007 2006
Cash flows from operating activities:
Net income $15,249 $38,201
Adjustments for noncash items:
Depreciation 45,892 44,132
Amortization of intangibles 149 149
Deferred income taxes (24,241) 10,155
Accrued pension income and
postretirement benefits (1,735) 3,178
Gain on sale of assets (2,699) (317)
Loss on asset impairments and
divestitures 34,382 1,150
Changes in assets and liabilities,
net of effects of acquisitions
and divestitures:
Accounts and notes receivables 15,786 151
Inventories 4,099 (5,080)
Income taxes recoverable 10,478 1,991
Prepaid expenses and other 764 (275)
Accounts payable 3,277 6,218
Accrued expenses (6,209) 5,374
Other, net 362 (296)
Net cash provided by operating
activities 95,554 104,731
Cash flows from investing activities:
Capital expenditures (20,643) (40,573)
Investments, including Harbinger
($10 million), a drug delivery
company ($6.5 million) and real
estate ($6.2 million) in 2007 (23,513) (542)
Proceeds from the sale of assets and
property disposals & reimbursements
from customers for purchases of
equipment 7,871 475
Net cash used in investing
activities (36,285) (40,640)
Cash flows from financing activities:
Dividends paid (6,126) (6,221)
Debt principal payments (39,964) (54,530)
Borrowings 59,500 4,000
Repurchases of Tredegar common stock,
net of settlement payable of $3,367 (73,959) -
Proceeds from exercise of stock options 6,471 9,576
Net cash used in financing
activities (54,078) (47,175)
Effect of exchange rate changes on cash 2,128 548
Increase in cash and cash equivalents 7,319 17,464
Cash and cash equivalents at beginning
of period 40,898 23,434
Cash and cash equivalents at end of
period $48,217 $40,898
Selected Financial Measures
(In Millions)
(Unaudited)
For the Twelve Months Ended
December 31, 2007
Film Aluminum
Products Extrusions Total
Operating profit from continuing
ongoing operations $59.4 $16.5 $75.9
Allocation of corporate overhead (8.4) (2.2) (10.6)
Add back depreciation and amortization
from continuing operations 34.1 8.5 42.6
Adjusted EBITDA from continuing
operations (h) $85.1 $22.8 $107.9
Selected balance sheet and other data
as of December 31, 2007:
Net debt (cash) (i) $33.8
Shares outstanding 34.8
Notes to the Financial Tables
(a) Plant shutdowns, asset impairments and restructurings in the fourth
quarter of 2007 include:
-- A pretax charge of $1.2 million related to the estimated loss on
the sub-lease of a portion of the AFBS (formerly Therics) facility
in Princeton, New Jersey;
-- A pretax charge of $256,000 for asset impairments in Film Products.
Plant shutdowns, asset impairments and restructurings in 2007 include:
-- A pretax charge of $2.8 million related to the estimated loss on
the sub-lease of a portion of the AFBS (formerly Therics) facility
in Princeton, New Jersey;
-- Pretax charges of $594,000 for asset impairments in Film Products;
-- A pretax charge of $592,000 for severance and other employee-
related costs in Aluminum Extrusions;
-- A pretax charge of $55,000 for costs related to the shutdown of the
films manufacturing facility in LaGrange, Georgia; and
-- A pretax charge of $42,000 related to expected future environmental
costs at the aluminum extrusions facility in Newnan, Georgia
(included in "Cost of goods sold" in the condensed consolidated
statements of income).
Plant shutdowns, asset impairments and restructurings in the fourth
quarter of 2006 include:
-- A net pretax gain associated with the shutdown of the films
manufacturing facility in LaGrange, Georgia, including a gain of
$280,000 for related LIFO inventory liquidations (included in "Cost
of goods sold" in the condensed consolidated statements of income)
and a gain of $261,000 on the sale of related property and
equipment (included in "Other income (expense), net" in the
condensed consolidated statements of income), partially offset by
other shutdown-related costs of $527,000; and
-- A pretax charge of $143,000 related to the estimated loss on the
sub-lease of a portion of the AFBS (formerly Therics) facility in
Princeton, New Jersey.
Plant shutdowns, asset impairments and restructurings in 2006 include:
-- A net pretax gain of $1.4 million associated with the shutdown of
the films manufacturing facility in LaGrange, Georgia, including a
gain of $2.9 million for related LIFO inventory liquidations
(included in "Cost of goods sold" in the condensed consolidated
statements of income) and a gain of $261,000 on the sale of related
property and equipment (included in "Other income (expense), net"
in the condensed consolidated statements of income), partially
offset by severance and other costs of $1.6 million and asset
impairment charges of $130,000;
-- Pretax charges of $1 million for asset impairments in Film
Products;
-- A pretax charge of $920,000 related to expected future
environmental costs at the aluminum extrusions facility in Newnan,
Georgia (included in "Cost of goods sold" in the condensed
consolidated statements of income);
-- Pretax charges of $727,000 for severance and other employee-related
costs in connection with restructurings in Film Products
($213,000) and Aluminum Extrusions ($514,000); and
-- A pretax charge of $637,000 related to the estimated loss on the
sub-lease of a portion of the AFBS (formerly Therics) facility in
Princeton, New Jersey.
(b) Gain on the sale of corporate assets in 2007 includes a gain related
to the sale of corporate real estate. Gain on the sale of corporate
assets in 2006 includes a gain related to the sale of public equity
securities.
The loss from the write-down of an investment of $2.1 million is
included in "Other income (expense), net" in the condensed
consolidated statements of income.
Income taxes in 2007 include the recognition of a valuation allowance
of $1.1 million in the third quarter for expected limitations on the
utilization of assumed capital losses on certain investments.
Income taxes in 2006 include a reversal of a valuation allowance of
$577,000 for deferred tax assets associated with capital loss
carryforwards recorded with the write-down of the investment in
Novalux. Outside appraisal of the value of corporate assets,
primarily real estate, performed in December 2006, indicated that
realization of related deferred tax assets is more likely than not.
(c) On February 12, 2008, Tredegar sold its aluminum extrusions business
in Canada for an estimated purchase price of $25.5 million to WXP
Holdings, Inc., an affiliate of H.I.G. Capital. The final purchase
price is subject to increase or decrease to the extent that actual
working capital as of February 12, 2008 is above or below the
estimated working capital used to determine the estimated purchase
price. Tredegar expects to realize cash income tax benefits in 2008
from the sale of approximately $11.4 million, which the company
recognized as a deferred income tax asset in its consolidated balance
sheet at December 31, 2007. All historical results for this business
have been reflected as discontinued operations in the accompanying
financial tables. The components of income (loss) from discontinued
operations are presented below:
Fourth
Quarter Ended Year Ended
December 31 December 31
(In thousands) 2007 2006 2007 2006
Income (loss) from operations
before income taxes $(376) $1,824 $(6,366) $3,729
Income tax cost (benefit) on
operations (108) 614 (2,199) 845
(268) 1,210 (4,167) 2,884
Loss associated with asset
impairments and disposal
activities (4,144) -- (31,755) --
Income tax cost (benefit) on
asset impairments and costs
associated disposal
activities (10,733) -- (16,241) --
6,589 -- (15,514) --
Income (loss) from discontinued
operations $6,321 $1,210 $(19,681) $2,884
In addition to the assets and liabilities shown separately in the
consolidated balance sheet for discontinued operations, shareholders'
equity includes net positive foreign currency translation adjustments,
pension and other postretirement benefit adjustments and unrealized
gains and losses on derivative financial instruments relating to
discontinued operations of $10.4 million and $5.0 million at December
31, 2007 and 2006, respectively.
(d) Comprehensive income (loss), defined as net income and other
comprehensive income (loss), was income of $33 million for the fourth
quarter of 2007 and income of $14.1 million for the fourth quarter of
2006. Comprehensive income (loss) was income of $49.9 million in 2007
and income of $46.3 million in 2006. Other comprehensive income
(loss) includes changes in unrealized gains and losses on available-
for-sale securities, foreign currency translation adjustments,
unrealized gains and losses on derivative financial instruments,
amortization of prior service cost and net gains or losses from
pension and other postretirement benefit plans, and in 2006, minimum
pension liability, all recorded net of deferred taxes directly in
shareholders' equity.
(e) On June 30, 2005, substantially all of the assets of AFBS, Inc.
(formerly Therics, Inc.), a wholly-owned subsidiary of Tredegar, were
sold or assigned to a newly-created limited liability company,
Therics, LLC, controlled and managed by an individual not affiliated
with Tredegar. AFBS retained substantially all of its liabilities in
the transaction, which included customary indemnification provisions
for pre-transaction liabilities. AFBS received a 17.5% equity
interest in the new company valued at $170,000 and a 3.5% interest in
Theken Spine, LLC valued at $800,000, along with potential future
payments on the sale of certain products by Therics, LLC.
(f) Effective January 1, 2006, Tredegar adopted SFAS No. 123(R), "Share-
Based Payment" (SFAS 123(R)) using the modified prospective method.
SFAS 123(R) requires the company to record compensation expense for
all share-based awards. Tredegar previously applied Accounting
Principles Board (APB) Opinion No. 25, "Accounting for Stock Issued to
Employees," and related interpretations and provided the required pro
forma disclosures of SFAS No. 123, "Accounting for Stock-Based
Compensation" (SFAS 123). Prior periods were not restated.
(g) Effective December 31, 2006, Tredegar adopted SFAS No. 158,
"Employers' Accounting for Defined Benefit Pension and Other
Postretirement Plans" (SFAS 158). This statement requires the
recognition in the balance sheet of the funded status of each of our
defined benefit pension and other postretirement plans. Each
overfunded plan is recognized as an asset and each underfunded plan is
recognized as a liability. The initial impact of SFAS 158, net of
deferred taxes, was recognized directly in shareholders' equity.
(h) Adjusted EBITDA for the twelve months ended December 31, 2007,
represents income from continuing operations before interest, taxes,
depreciation, amortization, unusual items and losses associated with
plant shutdowns, asset impairments and restructurings, gains from the
sale of assets, investment write-down, charges related to stock option
awards accounted for under the fair value-based method and other
items. Adjusted EBITDA is not intended to represent cash flow from
operations as defined by GAAP and should not be considered as either
an alternative to net income (as an indicator of operating
performance) or to cash flow (as a measure of liquidity). Tredegar
uses Adjusted EBITDA as a measure of unlevered (debt-free) operating
cash flow. We also use it when comparing relative enterprise values of
manufacturing companies and when measuring debt capacity. When
comparing the valuations of a peer group of manufacturing companies,
we express enterprise value as a multiple of Adjusted EBITDA. We
believe Adjusted EBITDA is preferable to operating profit and other
GAAP measures when applying a comparable multiple approach to
enterprise valuation because it excludes the items noted above,
measures of which may vary among peer companies.
(i) Net debt is calculated as follows (in millions):
Debt $82.0
Less: Cash and cash equivalents (48.2)
Net debt $33.8
Net debt is not intended to represent total debt or debt defined by
GAAP. Net debt is utilized by management in evaluating the company's
financial leverage and equity valuation and the company believes that
investors also may find net debt to be helpful for the same purposes.
SOURCE Tredegar Corporation
http://www.tredegar.com
